Compounds having the formula (I), ##STR1##

and pharmaceutically acceptable salts or prodrugs thereof, are useful as kinase inhibitors, wherein Y is —C(O)NR₁—, —NR₁C(O)—, —NR₁C(O)NR₁—, —NR₁SO₂—, —SO₂NR₁—, —C(O)—, —OC(O)—, or —CO₂—; B is alkyl, substituted alkyl, alkenyl, substituted alkenyl, hydroxy, alkoxy, aryl, cycloalkyl, heteroaryl, and heterocyclo; or when Y is —C(O)NR₁—, B also may be selected from —C(O)R₈, —C(O)NR₈R₉, and —CO₂R₈; R₁ is hydrogen, C_1-4alkyl, or substituted C_1-4alkyl; R₂ is hydrogen or C_1-4alkyl; R₃ is hydrogen, methyl, perfluoromethyl, hydroxy, methoxy, halogen, cyano, NH₂, or NH(CH₃); and R₄, R₅, R₆, R₇, R₈, and R₉ are as defined in the specification.